Table 2.
Observed and excess mortality rates, and standardized mortality ratios, among 64,836 HIV-infected patients initiating combination antiretroviral therapy in the China National Free Antiretroviral Treatment Program from 2003 – 2009
| Mortality | 2003–2004 | 2005–2007 | 2008–2009 | Total |
|---|---|---|---|---|
| Observed death | 733 | 3,815 | 4,029 | 8,577 |
| Expected death | 23.8 | 166.4 | 236.6 | 426.8 |
| Person year at follow up | 7,754 | 55,336 | 72,419 | 135,509 |
| Observed mortality rate (95% CI)† (per 100 person-years) | 9.5 (8.8 – 10.2) | 6.9 (6.7 – 7.1) | 5.6 (5.4 – 5.8) | 6.3 (6.2 – 6.4) |
| Excess mortality rate (95% CI)‡ (per 100 person-years) | 9.1 (8.5 – 9.8) | 6.6 (6.4 – 6.8) | 5.2 (5.0 – 5.4) | 6.0 (5.9 – 6.1) |
| Standardized mortality ratio (95% CI)* | 30.8 (28.6 – 33.1) | 22.9 (22.2 – 23.7) | 17.0 (16.5 – 17.6) | 20.1 (19.7 – 20.5) |
Calculated as 100× (observed death/person years at follow up)
Calculated as 100× [(observed death-expected death)/person years at follow up)]
Calculated as 100× (observed death/expected death)